Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatment for NSCLC With EGFR PACC or EGFR l861q Mutation

Allist Pharmaceuticals, Inc. · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
egfr
egfr, nsclc (advanced non-small cell lung cancer), firmonertinib, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 825938
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.